Rock Springs Capital Management LP Leap Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.29 - $0.72 $288,648 - $716,644	995,339 Added 27.2%	4,655,186 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$0.92 - $9.3 $6,348 - $64,170	6,900 Added 0.19%	3,659,847 $3.22 Million
Q2 2022 Aug 15, 2022	BUY	$0.96 - $1.91 $55,200 - $109,825	57,500 Added 1.6%	3,652,947 $4.2 Million
Q1 2022 May 16, 2022	BUY	$1.6 - $3.35 $119,803 - $250,837	74,877 Added 2.13%	3,595,447 $6.29 Million
Q4 2021 Feb 14, 2022	BUY	$2.08 - $3.65 $25,584 - $44,895	12,300 Added 0.35%	3,520,570 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $4.74 Million - $14.1 Million	3,508,270 New	3,508,270 $14.1 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.